Guidelines accompanied by changes in reimbursement rules Effects on lipid-lowering drug prescribing

Author： Bjerrum Lars   Larsen John   Kragstrup Jakob  

Publisher： Informa Healthcare

ISSN： 0281-3432

Source： Scandinavian Journal of Primary Health Care, Vol.19, Iss.3, 2001-09, pp. : 158-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid-lowering effects of colesevelam HCl in combination with ezetimibe

By Bays Harold   Rhyne James   Abby Stacey   Lai Yu-Ling   Jones Michael  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2191-2200

Informa Healthcare

Access to resources Recommend Favorite

Lipid-Lowering Drugs: Are Adverse Effects Predictable and Reversible?

By  

Cardiology, Vol. 97, Iss. 3, 2002-06 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

Comments on: Effects of clarithromycin in patients with active rheumatoid arthritis

By Saviola Gianantonio   Benucci Maurizio   Cirino Giuseppe  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2763-2764

Informa Healthcare

Access to resources Recommend Favorite

Rapid effects of different lipid-lowering drugs on PCSK9 in humans

By Liu Jun   Guo Yuan-Lin   Xu Rui-Xia   Li Jian-Jun  

Clinical Lipidology, Vol. 8, Iss. 5, 2013-10 ,pp. : 519-524

Future Medicine

Access to resources Recommend Favorite

Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?

By Krishnamoorthy Suresh   Lip Gregory YH  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 487-489

Future Medicine

Access to resources Recommend Favorite